Medical Community Warns Congress About Politicizing Vaccine Development
WASHINGTON — A congressional committee sought assurances from medical experts Wednesday that the COVID-19 vaccines pharmaceutical companies plan to distribute soon will protect the public from the disease.
Lawmakers were concerned that political pressure would force the companies to sacrifice the safety or effectiveness of a vaccine.
Rep. Diana DeGette, D-Colo., chairwoman of the House Energy and Commerce subcommittee on oversight and investigations said she wanted “to ensure science and not politics guides the way.”
The subcommittee held the hearing days after pharmaceutical companies, such as Moderna Inc. and AstraZeneca PLC, said they are nearing completion of the final stage of their tests. Promising results so far show their vaccines can generate antibodies in the recipients to protect them from COVID-19 infection.
At the same time, President Donald Trump has said a vaccine could be available publicly as soon as Nov. 1, only two days before the presidential election.
His assurances of quick access to the vaccine heightened public skepticism of its effectiveness, according to Democrats.
DeGette said recent opinion polls showed nearly two-thirds of Americans worry that political pressure will rush approval of a COVID-19 vaccine before it is safe.
Rep. Ann McLane Kuster, D-N.H., said, “The problem is that the president has politicized this vaccine coming just weeks before an election.”
Republicans, such as Rep. Brett Guthrie of Kentucky, did not blame the president but agreed “scientific experts, not politicians” should determine when a vaccine is ready. Republicans also said Trump’s statements were guided by his health advisors.
Most pharmaceutical companies and the Food and Drug Administration have not verified Trump’s prediction of vaccine availability by Nov. 1. Instead, they are predicting it would be given to essential workers and high-risk persons no sooner than the end of 2020 or early 2021.
Lower risk persons would get the vaccines later in 2021 as they become available from the manufacturers.
Cautionary statements about the Trump administration’s “Operation Warp Speed” rush toward a vaccine were shared by medical experts who testified at the congressional hearing Wednesday.
“We’ve got to restore the trust and confidence that has been eroded in vaccines,” said Helene Gayle, a National Academies of Sciences, Engineering and Medicine vaccine expert.
She said in her testimony that the vaccine development represents unprecedented progress but that false hopes promoted by the FDA in recent months have undermined public confidence in the agency. The FDA must approve any vaccine before it can be widely distributed.
Gayle mentioned the example of hydroxychloroquine, which the FDA approved as a COVID-19 treatment on March 28. The FDA revoked the approval in mid-June.
“What happened between March and June is well-known,” Gayle said. “Hydroxychloroquine was found to be more harmful than helpful and the president’s continued support of the treatment further divided the nation instead of building trust among all Americans.”
Even if an effective vaccine is distributed publicly soon, the health threat from COVID-19 will not disappear immediately, other doctors who testified said.
“It is not a silver bullet,” said Ashish K. Jha, dean of the Brown University’s School of Public Health.
Instead, the vaccine might be only 70% to 80% effective in preventing the disease, Jha said. In addition, the research has not determined whether vaccinated persons could remain carriers who spread COVID-19 to other persons, he said.
A more likely scenario is that the public will need to continue wearing masks and avoiding public gatherings for a couple more years until the pandemic subsides, he said.
In The News
Large hospital systems are grappling with how best to decide which health care workers will be vaccinated first for COVID-19, a daunting task when it's unclear which shots they'll get, how many and when they'll arrive. The first COVID-19 vaccine could be cleared for U.S. use as soon... Read More
Top federal officials voiced dire predictions of a nationwide post- Thanksgiving surge in COVID cases on Sunday. "What we expect, unfortunately, as we go for the next couple of weeks into December, (is) that we might see a surge superimposed upon that surge that we're already in," Dr. Anthony... Read More
WASHINGTON (AP) — As coronavirus cases surge again nationwide the Supreme Court late Wednesday barred New York from enforcing certain limits on attendance at churches and synagogues in areas designated as hard hit by the virus. The justices split 5-4 with new Justice Amy Coney Barrett in the... Read More
WASHINGTON — House Ways and Means Chairman Richard E. Neal's attitude toward legislating under a Democratic-led White House might aptly be described as "never let a crisis go to waste." The Massachusetts Democrat wants to take a page from his party's 2009 playbook, when the Obama administration took office amid the wreckage of... Read More
WASHINGTON — When the 117th Congress convenes in January, COVID-19 precautions will prevent the 435 House members from gathering in the chamber together, so opening day festivities of swearing in members and electing the speaker will look a little different. House leaders have begun discussing how to carry out... Read More
WASHINGTON — A top Senate Democrat said Tuesday that she's engaged in bipartisan discussions on COVID-19 aid and urged quick action even if that means "a short-term package for the next few months." "We need to act," said Sen. Debbie Stabenow, D- Mich., the fourth-ranking Democrat in that chamber... Read More